Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specific Senescence Program in Melanomas

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438 · see citing works

Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence

Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1× · see citing works

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548 · see citing works

The signals and pathways activating cellular senescence

Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046 · see citing works

Regulation of p53 in response to DNA damage

Lakin, N. D., & Jackson, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203015 · Cited by 987 · see citing works

Apoptosis and melanoma chemoresistance

Soengas, M. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206454 · Cited by 822 · see citing works

Guilty as charged

Garnett, M. J., & Marais, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.022 · Cited by 794 · see citing works

Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability

McGill, G. G., Horstmann, M. A., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y., Ramaswamy, S., Avery, W., Ding, H., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00762-6 · Cited by 760 · see citing works

Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence

Kortlever, R. M., Higgins, P. J., & Bernards, R. (2006) · Nature Cell Biology · doi:10.1038/ncb1448 · Cited by 637 · cited 2× · see citing works

Mitf regulation of Dia1 controls melanoma proliferation and invasiveness

Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K. S., Testori, A., Larue, L., & Goding, C. R. (2006) · Genes & Development · doi:10.1101/gad.406406 · Cited by 608 · see citing works

DNA damage signalling guards against activated oncogenes and tumour progression

Bartek, J., Bartkova, J., & Lukas, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210881 · Cited by 521 · see citing works

Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes

Bertolotto, C., Abbe, P., Hemesath, T. J., Bille, K., Fisher, D. E., Ortonne, J. P., & Ballotti, R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.827 · Cited by 511 · see citing works

Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF

Du, J., Widlund, H. R., Horstmann, M. A., Ramaswamy, S., Ross, K. N., Huber, W. E., Nishimura, E. K., Golub, T. R., & Fisher, D. E. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.014 · Cited by 420 · see citing works

p53 Binding Protein 53BP1 Is Required for DNA Damage Responses and Tumor Suppression in Mice

Ward, I. M., Minn, K. T., van Deursen, J., & Chen, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2556-2563.2003 · Cited by 412 · see citing works

The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence

Mallette, F. A., Gaumont-Leclerc, M.-F., & Ferbeyre, G. (2007) · Genes & Development · doi:10.1101/gad.1487307 · Cited by 406 · see citing works

Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation

Wu, C.-H., van Riggelen, J., Yetil, A., Fan, A. C., Bachireddy, P., & Felsher, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701953104 · Cited by 405 · see citing works

Cellular senescence in naevi and immortalisation in melanoma: a role for p16?

Gray-Schopfer, V. C., Cheong, S. C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z. A., Marais, R., Wynford-Thomas, D., & Bennett, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603283 · Cited by 394 · see citing works

Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression

Carreira, S., GOODALL, J. C., Aksan, I., Rocca, S. A. L., Galibert, M., Denat, L., Larue, L., & Goding, C. R. (2005) · Nature · doi:10.1038/nature03269 · Cited by 393 · see citing works

Fifteen-year quest for microphthalmia-associated transcription factor target genes

Chéli, Y., Ohanna, M., Ballotti, R., & Bertolotto, C. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00653.x · Cited by 362 · see citing works

Single-Stranded DNA Orchestrates an ATM-to-ATR Switch at DNA Breaks

Shiotani, B., & Zou, L. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.024 · Cited by 353 · see citing works

Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1

Veuger, S. J., Curtin, N. J., Richardson, C. J., Smith, G. C. M., & Durkacz, B. W. (2003) · PubMed · doi:10.25405/ncl.34607331 · Cited by 332 · see citing works

p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest

Ho, J. S. L., Ma, W., Mao, D. Y. L., & Benchimol, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7423-7431.2005 · Cited by 312 · see citing works

Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells

Viale, A., Franco, F., Orleth, A., Cambiaghi, V., Giuliani, V., Bossi, D., Ronchini, C., Ronzoni, S., Muradore, I., Monestiroli, S., et al. (2008) · Nature · doi:10.1038/nature07618 · Cited by 303 · see citing works

Inhibition of the Phosphoinositide 3-Kinase Pathway Induces a Senescence-like Arrest Mediated by p27Kip1

Collado, M., Medema, R. H., Garcı́a-Cao, I., Dubuisson, M., Barradas, M., Glassford, J., Rivas, C., Burgering, B. M. T., Serrano, M., & Lam, E. W. ‐. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000759200 · Cited by 268 · see citing works

C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells

Zhuang, D., Mannava, S., Grachtchouk, V., Tang, W. H., Patil, S. B., Wawrzyniak, J. A., Berman, A. E., Giordano, T. J., Prochownik, E. V., Soengas, M. S., et al. (2008) · Oncogene · doi:10.1038/onc.2008.258 · Cited by 202 · see citing works

Use of human tissue to assess the oncogenic activity of melanoma-associated mutations

Chudnovsky, Y., Adams, A. E., Robbins, P. B., Lin, Q., & Khavari, P. A. (2005) · Nature Genetics · doi:10.1038/ng1586 · Cited by 193 · see citing works

Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas

Bardeesy, N., Bastian, B. C., Hezel, A., Pinkel, D., DePinho, R. A., & Chin, L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2144-2153.2001 · Cited by 166 · see citing works

Tbx2 Directly Represses the Expression of the p21WAF1 Cyclin-Dependent Kinase Inhibitor

Prince, S., Carreira, S., Vance, K. W., Abrahams, A., & Goding, C. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3286 · Cited by 160 · see citing works

p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK

Boehme, K. A., Kulikov, R., & Blattner, C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703423105 · Cited by 151 · see citing works

Deregulation of the Rb and p53 Pathways in Uveal Melanoma

Brantley, M. A., & Harbour, J. W. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64817-1 · Cited by 131 · see citing works

Microphthalmia-Associated Transcription Factor Is a Critical Transcriptional Regulator of Melanoma Inhibitor of Apoptosis in Melanomas

Dynek, J. N., Chan, S. M., Liu, J., Zha, J., Fairbrother, W. J., & Vucic, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6622 · Cited by 109 · see citing works

IGF1 Promotes Resistance to Apoptosis in Melanoma Cells through an Increased Expression of BCL2, BCL-X(L), and Survivin

Hilmi, C., Larribère, L., Giuliano, S., Bille, K., Ortonne, J. P., Ballotti, R., & Bertolotto, C. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701185 · Cited by 104 · see citing works

Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage

Yokoyama, S., Feige, E., Poling, L. L., Levy, C., Widlund, H. R., Khaled, M., Kung, A. L., & Fisher, D. E. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00480.x · Cited by 104 · see citing works

Regulation of CHK2 by DNA-dependent Protein Kinase

Li, J., & Stern, D. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412445200 · Cited by 102 · see citing works

Microphthalmia Associated Transcription Factor Is a Target of the Phosphatidylinositol-3-Kinase Pathway

Khaled, M., Larribère, L., Bille, K., Ortonne, J. P., Ballotti, R., & Bertolotto, C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12420.x · Cited by 92 · see citing works

PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes

Larribère, L., Khaled, M., Tartare‐Deckert, S., Buscà, R., Luciano, F., Bille, K., Valony, G., Eychène, A., Auberger, P., Ortonne, J. ‐., et al. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401475 · Cited by 91 · see citing works

p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells

Eymin, B., Haugg, M., Droin, N. M., Sordet, O., Dimanche‐Boitrel, M., & Solary, É. (1999) · Oncogene · doi:10.1038/sj.onc.1202437 · Cited by 88 · see citing works

Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi

Bandyopadhyay, D., Curry, J. L., Lin, Q., Richards, H. W., Chen, D., Hornsby, P. J., Timchenko, N. A., & Medrano, E. E. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00308.x · Cited by 81 · see citing works

The Role of BRAF Mutation and p53 Inactivation during Transformation of a Subpopulation of Primary Human Melanocytes

Yu, H., McDaid, R., Lee, J., Possik, P. A., Li, L., Kumar, S. M., Elder, D. E., Belle, P. A. V., Gimotty, P. A., Guerra, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081057 · Cited by 78 · see citing works

Urokinase-Type and Tissue-Type Plasminogen Activators as Growth Factors of Human Fibroblasts

Petro, G. D., Copeta, A., & Barlati, S. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1200 · Cited by 76 · see citing works

The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosisPreprint

Larribère, L., Hilmi, C., Khaled, M., Gaggioli, C., Bille, K., Auberger, P., Ortonne, J. P., Ballotti, R., & Bertolotto, C. (2005) · Genes & Development · doi:10.1101/gad.335905 · Cited by 67 · see citing works

DNA repair pathways involved in anaphase bridge formation

Açılan, C., Potter, D. M., & Saunders, W. S. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20425 · Cited by 66 · see citing works

Phosphorylation of p53 on Ser15 during cell cycle and caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation

Zhao, H. L., Traganos, F., & Darżynkiewicz, Z. (2008) · Cell Cycle · doi:10.4161/cc.7.19.6750 · Cited by 65 · see citing works

Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf

Nakai, N., Kishida, T., Shin‐Ya, M., Imanishi, J., Ueda, Y., Kishimoto, S., & Mazda, O. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302868 · Cited by 60 · see citing works

In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model

Brassart‐Pasco, S., Ramont, L., Ventéo, L., Pluot, M., Maquart, F., & Monboisse, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.036 · Cited by 59 · see citing works

Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications

Halaban, R., Krauthammer, M. O., Pelizzola, M., Cheng, E., Kovacs, D., Sznol, M., Ariyan, S., Narayan, D., Bacchiocchi, A., Molinaro, A. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004563 · Cited by 58 · see citing works

CDK2 translational down-regulation during endothelial senescence

Freedman, D. A., & Folkman, J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.03.025 · Cited by 44 · see citing works

Simultaneous suppression of MITF and BRAFV600E enhanced inhibition of melanoma cell proliferation

Kido, K., Sumimoto, H., Asada, S., Okada, S., Yaguchi, T., Kawamura, N., Miyagishi, M., Saida, T., & Kawakami, Y. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01266.x · Cited by 37 · see citing works

Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER‐α and chromatin remodelers during proliferation and senescence of human melanocytes

Schwahn, D. J., Timchenko, N. A., Shibahara, S., & Medrano, E. E. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00229.x · Cited by 36 · see citing works

A randomized Phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma

Chang, A. Y., Kim, K., Boucher, H., Bonomi, P., Stewart, J. A., Karp, D. D., & Blum, R. H. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980115)82:2

Cancer stem cells versus phenotype‐switching in melanoma

Hoek, K. S., & Goding, C. R. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00757.x · Cited by 494 · see citing works

MITF-the first 25 years

Goding, C. R., & Arnheiter, H. (2019) · Genes & Development · doi:10.1101/gad.324657.119 · Cited by 430 · see citing works

The melanocyte lineage in development and disease

Mort, R. L., Jackson, I. J., & Patton, E. E. (2015) · Development · doi:10.1242/dev.106567 · Cited by 416 · see citing works

Mechanisms and prevention of <scp>UV</scp>‐induced melanoma

Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology &amp; Photomedicine · doi:10.1111/phpp.12329 · Cited by 372 · see citing works

Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunitiesPreprint

Rambow, F., Marine, J., & Goding, C. R. (2019) · Genes & Development · doi:10.1101/gad.329771.119 · Cited by 347 · see citing works

MITF in melanoma: mechanisms behind its expression and activity

Hartman, M. L., & Czyż, M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1791-0 · Cited by 319 · see citing works

Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma

Strub, T., Giuliano, S., Ye, T., Bonet, C., Keime, C., Kobi, D., Le Gras, S., Cormont, M., Ballotti, R., Bertolotto, C., et al. (2011) · Oncogene · doi:10.1038/onc.2010.612 · Cited by 269 · see citing works

Senescent cells develop a parp-1 and nuclear factor-κB-associated secretome (PNAS).

Ohanna, M., Giuliano, S., Bonet, C., Imbert, V., Hofman, V., Zangari, J., Bille, K., Robert, C., Bressac-de Paillerets, B., Hofman, P., et al. (2011) · Genes &amp; Development · doi:10.1101/gad.625811 · Cited by 267 · see citing works

Keeping the senescence secretome under control: molecular reins on the senescence-associated secretory phenotype.

Malaquin, N., Martinez, A., & Rodier, F. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.010 · Cited by 247 · see citing works

Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanomaPreprint

Falletta, P., Sánchez‐del‐Campo, L., Chauhan, J. S., Effern, M., Kenyon, A., Kershaw, C. J., Siddaway, R., Lisle, R., Freter, R., Daniels, M. J., et al. (2017) · Genes & Development · doi:10.1101/gad.290940.116 · Cited by 239 · see citing works

MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment

Riesenberg, S., Groetchen, A., Siddaway, R., Bald, T., Reinhardt, J., Smorra, D., Sirokay, J. D., Renn, M., Phung, B., Aymans, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms9755 · Cited by 238 · see citing works

Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma

LaFave, L. M., Kartha, V. K., Ma, S., Meli, K., Priore, I. S. D., Lareau, C. A., Naranjo, S., Westcott, P. M. K., Duarte, F. M., Sankar, V., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.006 · Cited by 207 · see citing works

Microphthalmia‐associated transcription factor in melanoma development and MAP ‐kinase pathway targeted therapy

Wellbrock, C., & Arozarena, I. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12370 · Cited by 218 · see citing works

Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications

Fischer, G. M., Gopal, Y. N. V., McQuade, J. L., Peng, W., DeBerardinis, R. J., & Davies, M. A. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12661 · Cited by 200 · see citing works

Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells

Cheli, Y., Giuliano, S., Fenouille, N., Allegra, M., Hofman, V, Hofman, P., Bahadoran, P., Lacour, J.-P., Tartare-Deckert, S., Bertolotto, C., et al. (2012) · Oncogene · doi:10.1038/onc.2011.425 · Cited by 185 · see citing works

The roles of microphthalmia-associated transcription factor and pigmentation in melanoma

Hsiao, J. J., & Fisher, D. E. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.019 · Cited by 148 · see citing works

Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance

Ahmed, F., & Haass, N. K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00173 · Cited by 153 · see citing works

Melanoma: From Melanocyte to Genetic Alterations and Clinical Options

Bertolotto, C. (2013) · Scientifica · doi:10.1155/2013/635203 · Cited by 131 · see citing works

Epithelial‐to‐mesenchymal‐like transition events in melanoma

Pedri, D., Karras, P., Landeloos, E., Marine, J., & Rambow, F. (2021) · FEBS Journal · doi:10.1111/febs.16021 · Cited by 126 · see citing works

The melanocyte lineage in development and disease

Mort, R. L., Jackson, I. J., & Patton, E. E. (2015) · Development · doi:10.1242/dev.123729 · Cited by 118 · see citing works

Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways

Bai, X., Fisher, D. E., & Flaherty, K. T. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0204-6 · Cited by 107 · see citing works

Focus on cutaneous and uveal melanoma specificitiesPreprint

Pandiani, C., Béranger, G. E., Leclerc, J., Ballotti, R., & Bertolotto, C. (2017) · Genes & Development · doi:10.1101/gad.296962.117 · Cited by 110 · see citing works

SOX10 Ablation Arrests Cell Cycle, Induces Senescence, and Suppresses Melanomagenesis

Cronin, J. C., Watkins‐Chow, D. E., Incao, A. A., Hasskamp, J. H., Schönewolf, N., Aoude, L. G., Hayward, N. K., Bastian, B. C., Dummer, R., Loftus, S. K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4620 · Cited by 104 · see citing works

A Conditional Zebrafish MITF Mutation Reveals MITF Levels Are Critical for Melanoma Promotion vs. Regression In Vivo

Lister, J. A., Capper, A., Zeng, Z., Mathers, M. E., Richardson, J., Paranthaman, K., Jackson, I. J., & Patton, E. E. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.293 · Cited by 98 · see citing works

The MITF family of transcription factors: Role in endolysosomal biogenesis, Wnt signaling, and oncogenesis

Ploper, D., & Robertis, E. M. D. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.006 · Cited by 93 · see citing works

MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance

Gelmi, M. C., Houtzagers, L. E., Strub, T., Krossa, I., & Jager, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116001 · Cited by 115 · see citing works

W nt5 A promotes an adaptive, senescent‐like stress response, while continuing to drive invasion in melanoma cells

Webster, M. R., Xu, M., Kinzler, K. A., Kaur, A., Appleton, J., O’Connell, M. P., Marchbank, K., Valiga, A. A., Dang, V. M., Perego, M., et al. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12330 · Cited by 86 · see citing works

MITF reprograms the extracellular matrix and focal adhesion in melanoma

Dilshat, R., Fock, V., Kenny, C., Gerritsen, I., Lasseur, R. M. J., Trávníčková, J., Eichhoff, O. M., Cerny, P., Möller, K., Sigurbjörnsdóttir, S., et al. (2021) · eLife · doi:10.7554/elife.63093 · Cited by 82 · see citing works

BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export

Ngeow, K. C., Friedrichsen, H. J., Li, L., Zeng, Z., Andrews, S., Volpon, L., Brunsdon, H., Berridge, G., Picaud, S., Fischer, R., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810498115 · Cited by 82 · see citing works

Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation

Coassolo, S., Davidson, G., Négroni, L., Gambi, G., Daujat, S., Romier, C., & Davidson, I. (2021) · Nature Communications · doi:10.1038/s41467-021-21960-4 · Cited by 79 · see citing works

MC1R Functions, Expression, and Implications for Targeted Therapy

Guida, S., Guida, G., & Goding, C. R. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.06.018 · Cited by 81 · see citing works

Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype

Ohanna, M., Cheli, Y., Bonet, C., Bonazzi, V. F., Allegra, M., Giuliano, S., Bille, K., Bahadoran, P., Giacchero, D., Lacour, J. P., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1143 · Cited by 78 · see citing works

Melanoma Cells Revive an Embryonic Transcriptional Network to Dictate Phenotypic Heterogeneity

Vandamme, N., & Berx, G. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00352 · Cited by 77 · see citing works

Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells

Bonet, C., Giuliano, S., Ohanna, M., Bille, K., Allégra, M., Lacour, J. ‐., Bahadoran, P., Rocchi, S., Ballotti, R., & Bertolotto, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371682 · Cited by 77 · see citing works

Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis

Hölzel, M., & Tüting, T. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.03.009 · Cited by 80 · see citing works

A picture of Mitf in melanoma immortality

Goding, C. R. (2011) · Oncogene · doi:10.1038/onc.2010.641 · Cited by 68 · see citing works

The three M’s: melanoma, microphthalmia‐associated transcription factor and microRNA

Bell, R. E., & Levy, C. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00931.x · Cited by 74 · see citing works

The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma

Ahn, A., Chatterjee, A., & Eccles, M. R. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0535 · Cited by 70 · see citing works

ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition

Guo, W., Ma, J., Yang, Y., Guo, S., Zhang, W., Zhao, T., Yi, X., Wang, H., Wang, S., Liu, Y., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1359 · Cited by 68 · see citing works

A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF

Choi, J., Xu, M., Makowski, M. M., Zhang, T., Law, M. H., Kovacs, M. A., Granzhan, A., Kim, W. J., Parikh, H. M., Gartside, M. G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3927 · Cited by 64 · see citing works

Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution

Louphrasitthiphol, P., Siddaway, R., Loffreda, A., Pogenberg, V., Friedrichsen, H. J., Schepsky, A., Zeng, Z., Lu, M. M., Strub, T., Freter, R., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.025 · Cited by 62 · see citing works

SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells

Ohanna, M., Bonet, C., Bille, K., Allégra, M., Davidson, I., Bahadoran, P., Lacour, J. ‐., Ballotti, R., & Bertolotto, C. (2014) · Oncotarget · doi:10.18632/oncotarget.1791 · Cited by 62 · see citing works

Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells

Lai, M., Realini, N., Ferla, M. L., Passalacqua, I., Matteoli, G., Ganesan, A. K., Pistello, M., Mazzanti, C. M., & Piomelli, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-07606-w · Cited by 62 · see citing works

MITF and BRN2 contribute to metastatic growth after dissemination of melanoma

Simmons, J. L., Pierce, C. J., Al‐Ejeh, F., & Boyle, G. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-11366-y · Cited by 61 · see citing works

The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?

Ballotti, R., Chéli, Y., & Bertolotto, C. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01290-7 · Cited by 60 · see citing works

MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma

Kim, E. J., Zucconi, B. E., Wu, M., Nocco, S. E., Meyers, D. J., McGee, J. S., Venkatesh, S., Cohen, D. L., Gonzalez, E. C., Ryu, B., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2331 · Cited by 53 · see citing works

Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP

Wang, R., He, Y., Robinson, V. A., Yang, Z., Hessler, P., Lasko, L. M., Lu, X. L., Bhathena, A., Lai, A., Uziel, T., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0511 · Cited by 51 · see citing works

Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells

Koludrović, D., Laurette, P., Strub, T., Keime, C., Coz, M. L., Coassolo, S., Mengus, G., Larue, L., & Davidson, I. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005555 · Cited by 50 · see citing works

How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance

Wessely, A., Steeb, T., Berking, C., & Heppt, M. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115761 · Cited by 45 · see citing works

E2F1 inhibition mediates cell death of metastatic melanoma

Rouaud, F., Hamouda‐Tekaya, N., Cerezo, M., Abbe, P., Zangari, J., Hofman, V., Ohanna, M., Mograbi, B., Hachem, N. E., Benfodda, Z., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0566-1 · Cited by 46 · see citing works

Phosphorylation of MITF by AKT affects its downstream targets and causes TP53-dependent cell senescence

Wang, C., Zhao, L., Su, Q., Fan, X., Wang, Y., Gao, S., Wang, H., Chen, H., Chan, C. B., & Liu, Z. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.029 · Cited by 44 · see citing works

Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells

Leclerc, J., Garandeau, D., Pandiani, C., Gaudel, C., Bille, K., Nottet, N., Garcia, V., Colosetti, P., Pagnotta, S., Bahadoran, P., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0500-0 · Cited by 45 · see citing works

The MITF regulatory network in melanoma

Chauhan, J. S., Hölzel, M., Lambert, J., Buffa, F. M., & Goding, C. R. (2022) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13053 · Cited by 41 · see citing works

Thymine DNA glycosylase as a novel target for melanoma

Mancuso, P., Tricarico, R., Bhattacharjee, V., Cosentino, L., Kadariya, Y., Jelı́nek, J., Nicolas, É., Einarson, M. B., Beeharry, N., Devarajan, K., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0640-2 · Cited by 44 · see citing works

Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression

Bonet, C., Luciani, F., Ottavi, J., Leclerc, J., Jouenne, F.-M., Boncompagni, M., Bille, K., Hofman, V., Bossis, G., Donatis, G. M. D., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw340 · Cited by 40 · see citing works

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Hmada, Y. A., Brodell, R. T., Kharouf, N., Flanagan, T. W., AlAmodi, A. A., Hassan, S.-Y., Shalaby, H., Hassan, S.-L., Haïkel, Y., Megahed, M., et al. (2024) · Cancers · doi:10.3390/cancers16020470 · Cited by 41 · see citing works

Pathways from senescence to melanoma: focus on MITF sumoylation

Leclerc, J., Ballotti, R., & Bertolotto, C. (2017) · Oncogene · doi:10.1038/onc.2017.292 · Cited by 43 · see citing works

Microphthalmia‐associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation

Vachtenheim, J., & Ondrušová, Ľ. (2015) · Experimental Dermatology · doi:10.1111/exd.12724 · Cited by 37 · see citing works

Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention

Manganelli, M., Guida, S., Ferretta, A., Pellacani, G., Porcelli, L., Azzariti, A., & Guida, G. (2021) · Genes · doi:10.3390/genes12071093 · Cited by 37 · see citing works

FANCD2 functions as a critical factor downstream of MiTF to maintain the proliferation and survival of melanoma cells

Bourseguin, J., Bonet, C., Renaud, E., Pandiani, C., Boncompagni, M., Giuliano, S., Pawlikowska, P., Karmous‐Benailly, H., Ballotti, R., Rosselli, F., et al. (2016) · Scientific Reports · doi:10.1038/srep36539 · Cited by 36 · see citing works

Advances in melanoma senescence and potential clinical application

Giuliano, S., Ohanna, M., Ballotti, R., & Bertolotto, C. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00820.x · Cited by 34 · see citing works

A germline oncogenic MITF mutation and tumor susceptibility

Paillerets, B. B., Lesueur, F., & Bertolotto, C. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.10.002 · Cited by 33 · see citing works

A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF

Borgdorff, V., Rix, U., Winter, G. E., Gridling, M., Müller, A. C., Breitwieser, F. P., Wagner, C., Colinge, J., Bennett, K. L., Superti‐Furga, G., et al. (2013) · Oncogene · doi:10.1038/onc.2013.185 · Cited by 32 · see citing works

Mitofusins modulate the increase in mitochondrial length, bioenergetics and secretory phenotype in therapy-induced senescent melanoma cells

Martínez, J., Tarallo, D., Palma, L. M., Victoria, S., Bresque, M., Rodríguez-Bottero, S., Marmisolle, I., Escande, C., Cassina, P., Casanova, G., et al. (2019) · Biochemical Journal · doi:10.1042/bcj20190405 · Cited by 29 · see citing works

Regulatory and Functional Connection of Microphthalmia-Associated Transcription Factor and Anti-Metastatic Pigment Epithelium Derived Factor in Melanoma

Fernández‐Barral, A., Orgaz, J. L., Baquero, P., Ali, Z., Moreno, A., Tiana, M., Gómez, V., Riveiro‐Falkenbach, E., Cañadas, C., Zazo, S., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.06.001 · Cited by 30 · see citing works

Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion

Mannava, S., Moparthy, K., Wheeler, L. J., Leonova, K. I., Wawrzyniak, J. A., Bianchi, A., Berman, A. E., Flanagan, S. A., Shewach, D. S., Zeitouni, N. C., et al. (2012) · Aging · doi:10.18632/aging.100512 · Cited by 30 · see citing works

Genetic and functional evaluation of MITF as a candidate gene for cutaneous melanoma predisposition in pigs

Bourneuf, E., Du, Z., Estellé, J., Gilbert, H., Créchet, F., Piton, G., Denis Milan, A., Geffrotin, C., Lathrop, M. G., Démenais, F., et al. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9334-6 · Cited by 29 · see citing works

Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer

Delahaye, C., Figarol, S., Pradines, A., Favre, G., Mazières, J., & Calvayrac, O. (2022) · Cancers · doi:10.3390/cancers14112613 · Cited by 28 · see citing works

Amino acid cysteine induces senescence and decelerates cell growth in melanoma

Chu, P., & Liu, M. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.08.010 · Cited by 27 · see citing works

BRCA1 is a new MITF target gene

Beuret, L., Ohanna, M., Strub, T., Allégra, M., Davidson, I., Bertolotto, C., & Ballotti, R. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00862.x · Cited by 27 · see citing works

Migration and fate of vestibular melanocytes during the development of the human inner ear

van Beelen, E. S. A., van der Valk, W. H., de Groot, J. C. M. J., Hensen, E. F., Locher, H., & van Benthem, P. P. G. (2020) · Developmental Neurobiology · doi:10.1002/dneu.22786 · Cited by 27 · see citing works

Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours

Howlin, J., Cirenajwis, H., Lettiero, B., Staaf, J., Lauss, M., Saal, L. H., Borg, Å., Gruvberger-Saal, S. K., & Jönsson, G. B. (2015) · PeerJ · doi:10.7717/peerj.788 · Cited by 26 · see citing works

Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells

Grabacka, M., Wieczorek, J., Michalczyk‐Wetula, D., Malinowski, M., Wolan, N., Wojcik, K., & Plonka, P. M. (2017) · Archives of Dermatological Research · doi:10.1007/s00403-016-1711-2 · Cited by 25 · see citing works

NME2 Is a Master Suppressor of Apoptosis in Gastric Cancer Cells via Transcriptional Regulation of miR-100 and Other Survival Factors

Gong, Y., Yang, G., Wang, Q., Wang, Y., & Zhang, X. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0612 · Cited by 25 · see citing works

TBX 2 expression is regulated by PAX 3 in the melanocyte lineage

Liu, F., Cao, J., Lv, J., Dong, L., Pier, E., Xu, G., Wang, R., Xu, Z., Goding, C. R., & Cui, R. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12029 · Cited by 25 · see citing works

ABCB5 is activated by MITF and β‐catenin and is associated with melanoma differentiation

Louphrasitthiphol, P., Chauhan, J. S., & Goding, C. R. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12830 · Cited by 22 · see citing works

ATM and p53 in aging and cancer: a double-edged sword in genomic integrity

Pandey, S. N., Afzal, M., Uikey, J., Ganesan, S., Mishra, S., Bansal, P., Kazmi, I. A., Alzarea, S. I., Almalk, W. H., Goyal, K., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10249-4 · Cited by 21 · see citing works

MITF-Independent Pro-Survival Role of BRG1-Containing SWI/SNF Complex in Melanoma Cells

Ondrušová, Ľ., Vachtenheim, J., Réda, J., Žáková, P., & Benková, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054110 · Cited by 21 · see citing works

P6981, An Arylstibonic Acid, Is a Novel Low Nanomolar Inhibitor of cAMP Response Element-Binding Protein Binding to DNA

Zhao, J., Stagno, J. R., Varticovski, L., Nimako, E., Rishi, V., McKinnon, K., Akee, R. K., Shoemaker, R. H., Ji, X., & Vinson, C. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080820 · Cited by 21 · see citing works

The Role of Senescent Cells in Acquired Drug Resistance and Secondary Cancer in BRAFi-Treated Melanoma

Thompson, E. L., Hu, J., & Niedernhofer, L. J. (2021) · Cancers · doi:10.3390/cancers13092241 · Cited by 19 · see citing works

Microphthalmia‐associated transcription factor/T‐box factor‐2 axis acts through Cyclin D1 to regulate melanocyte proliferation

Pan, L., Ma, X., Wen, B., Su, Z., Zheng, X.-T., Liu, Y., Li, H., Chen, Y., Wang, J., Lü, F., et al. (2015) · Cell Proliferation · doi:10.1111/cpr.12227 · Cited by 20 · see citing works

BAF60A mediates interactions between the microphthalmia‐associated transcription factor and the BRG1‐containing SWI/SNF complex during melanocyte differentiation

Aras, S., Saladi, S. V., Basuroy, T., Marathe, H. G., Lorès, P., & de la Serna, I. L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27840 · Cited by 20 · see citing works

The role of transcription factors in the acquisition of the four latest proposed hallmarks of cancer and corresponding enabling characteristics

Morgan, M. P., Finnegan, E., & Das, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.002 · Cited by 18 · see citing works

Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia

Oppezzo, A., Bourseguin, J., Renaud, E., Pawlikowska, P., & Rosselli, F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci131540 · Cited by 18 · see citing works

Hypoxia-Independent Drivers of Melanoma Angiogenesis

Meierjohann, S. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00102 · Cited by 17 · see citing works

Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-Mhigh melanoma cell populations

Hartman, M. L., Talar, B., Sztiller-Sikorska, M., Nejc, D., & Czyż, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7030 · Cited by 17 · see citing works

Phenotypic melanoma heterogeneity is regulated through cell-matrix interaction-dependent changes in tumor microarchitecturePreprint

Spoerri, L., Tonnessen-Murray, C. A., Gunasingh, G. P., Hill, D. S., Beaumont, K. A., Jurek, R. J., Chauhan, J. S., Vanwalleghem, G. C., Fane, M. E., Daignault, S. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.09.141747 · Cited by 16 · see citing works

Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms

Papke, D. J., & Hornick, J. L. (2021) · Histopathology · doi:10.1111/his.14450 · Cited by 15 · see citing works

MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells

Estrada, C., Mirabal-Ortega, L., Mery, L., Dingli, F., Besse, L., Messaoudi, C., Loew, D., Pouponnot, C., Bertolotto, C., Eychène, A., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03049-w · Cited by 15 · see citing works

Gene fusions in superficial mesenchymal neoplasms: Emerging entities and useful diagnostic adjuncts

Fischer, G. M., & Papke, D. J. (2023) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2023.04.014 · Cited by 14 · see citing works

Genetic Determinants of Uveal Melanoma

Couturier, J., & Saule, S. (2011) · Developments in ophthalmology · doi:10.1159/000328270 · Cited by 12 · see citing works

Fishful thinking: the rise and fall of MITF in melanoma

Goding, C. R. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12177 · Cited by 10 · see citing works

PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity

Maskin, C. R., Raman, R., & Houvras, Y. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-08936-0 · Cited by 10 · see citing works

Identification of novel NF‐κB transcriptional targets in TNFα‐treated HeLa and HepG2 cells

Zhou, F., Xu, X., Wang, D., Wu, J., & Wang, J. (2017) · Cell Biology International · doi:10.1002/cbin.10762 · Cited by 10 · see citing works

Inhibitor of differentiation‐4 (Id4) stimulates pigmentation in melanoma leading to histiocyte infiltration

DiVito, K. A., Trabosh, V. A., Chen, Y., Simbulan-Rosenthal, C. M., & Rosenthal, D. S. (2014) · Experimental Dermatology · doi:10.1111/exd.12582 · Cited by 10 · see citing works

Exosomes Derived from Hypertrophic Scar Fibroblasts Suppress Melanogenesis in Normal Human Epidermal Melanocytes

Cui, H. S., Joo, S. Y., Cho, Y. S., Lee, Y. R., Ro, Y. M., Kwak, I. S., Hur, G. Y., & Seo, C. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137236 · Cited by 9 · see citing works

DNA damage remodels the MITF interactome to increase melanoma genomic instabilityPreprint

Binet, R., Lambert, J., Tomková, M., Tischfield, S., Baggiolini, A., Picaud, S., Sarkar, S., Louphrasitthiphol, P., Dias, D., Carreira, S., et al. (2024) · Genes & Development · doi:10.1101/gad.350740.123 · Cited by 9 · see citing works

Microphthalmia-Associated Transcription Factor in Senescence and Age-Related Diseases

Zhang, J., Mou, Y., Gong, H., Chen, H., & Xiao, H. (2021) · Gerontology · doi:10.1159/000515525 · Cited by 8 · see citing works

MITF, TFEB, and TFE3 drive distinct adaptive gene expression programs and immune infiltration in melanoma

Dias, D., de Oliveira, E. A., Martí-Díaz, R., Andrews, S., Chocarro‐Calvo, A., Bellini, A., Mosteo, L., Vivas, Y., Chauhan, J. S., Li, L., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116499 · Cited by 7 · see citing works

Microphthalmia Transcription Factor almost Thirty Years after: Its Role in Melanogenesis and its Plant-Derived Inhibitors

Firmansyah, D., Indriaty, S., Sumiwi, S. A., Saptarini, N. M., & Levita, J. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00472 · Cited by 7 · see citing works

Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma

Strub, T., Giuliano, S., Ye, T., Bonet, C., Keime, C., Kobi, D., Le Gras, S., Cormont, M., Ballotti, R., Bertolotto, C., et al. (2011) · Oncogene · doi:10.1038/onc.2010.612 · Cited by 269 · see citing works

A picture of Mitf in melanoma immortality

Goding, C. R. (2011) · Oncogene · doi:10.1038/onc.2010.641 · Cited by 68 · see citing works

Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-Mhigh melanoma cell populations

Hartman, M. L., Talar, B., Sztiller-Sikorska, M., Nejc, D., & Czyż, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7030 · Cited by 17 · see citing works

Role of melanoma inhibitory activity in melanocyte senescence

Feuerer, L., Lamm, S., Henz, I., Kappelmann‐Fenzl, M., Haferkamp, S., Meierjohann, S., Hellerbrand, C., Kuphal, S., & Bosserhoff, A. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12801 · Cited by 23 · see citing works

Phosphorylation of MITF by AKT affects its downstream targets and causes TP53-dependent cell senescence

Wang, C., Zhao, L., Su, Q., Fan, X., Wang, Y., Gao, S., Wang, H., Chen, H., Chan, C. B., & Liu, Z. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.029 · Cited by 44 · see citing works